A Study of DB-1311 in Combination With BNT327 in People With Solid Tumor Cancer

Full Title

A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Maria Rubinstein’s office at 646-888-6954.

Protocol
26-105
Phase
Phase II (phase 2)
Disease Status
Newly Diagnosed & Relapsed/Refractory
Investigator
Maria Rubinstein
Co-Investigators
Vicky Makker
Diseases
Gynecologic Cancer › Cervical Cancer
Gynecologic Cancer › Ovarian Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06953089
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description